Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryFree Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Creative Medical Technology Holdings (CELZ) over the last 9 years, with Q1 2025 value amounting to $3485.0.

  • Creative Medical Technology Holdings' Share-based Compensation fell 6196.25% to $3485.0 in Q1 2025 from the same period last year, while for Sep 2025 it was $12647.0, marking a year-over-year decrease of 6549.06%. This contributed to the annual value of $36648.0 for FY2024, which is 0.0% changed from last year.
  • Per Creative Medical Technology Holdings' latest filing, its Share-based Compensation stood at $3485.0 for Q1 2025, which was down 6196.25% from $9162.0 recorded in Q4 2024.
  • In the past 5 years, Creative Medical Technology Holdings' Share-based Compensation registered a high of $383612.0 during Q3 2021, and its lowest value of $3485.0 during Q1 2025.
  • In the last 5 years, Creative Medical Technology Holdings' Share-based Compensation had a median value of $9162.0 in 2022 and averaged $37795.6.
  • In the last 5 years, Creative Medical Technology Holdings' Share-based Compensation plummeted by 9761.16% in 2022 and then skyrocketed by 110.35% in 2023.
  • Over the past 5 years, Creative Medical Technology Holdings' Share-based Compensation (Quarter) stood at $383612.0 in 2021, then crashed by 97.61% to $9162.0 in 2022, then changed by 0.0% to $9162.0 in 2023, then changed by 0.0% to $9162.0 in 2024, then crashed by 61.96% to $3485.0 in 2025.
  • Its last three reported values are $3485.0 in Q1 2025, $9162.0 for Q4 2024, and $9162.0 during Q3 2024.